Keryx Biopharmaceuticals (NASDAQ:KERX) CEO Ron Bentsur sold 5,257 shares of the company’s stock on the open market in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $12.57, for a total transaction of $66,080.49. Following the sale, the chief executive officer now directly owns 880,419 shares of […]
Insider Selling: Keryx Biopharmaceuticals CEO Sells 5,257 Shares of Stock (KERX) is a post from: Zolmax
The post Insider Selling: Keryx Biopharmaceuticals CEO Sells 5,257 Shares of Stock (KERX) appeared first on Zolmax.